Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment

Autor: Christophe Deroanne, Alain Colige, Jérôme Willems, Stéphane Demine, Laura Brohée, Thierry Arnould
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Male
RHOA
Time Factors
lipin-1
Apoptosis
chemistry.chemical_compound
Cell Movement
Antineoplastic Combined Chemotherapy Protocols
Molecular Targeted Therapy
Phosphorylation
Ribosomal Protein S6
Prostate cancer
Antibiotics
Antineoplastic

TOR Serine-Threonine Kinases
Lipin-1
Nuclear Proteins
Phosphatidic acid
prostate cancer
Propranolol
Cell biology
Oncology
Ribosomal protein s6
Female
RNA Interference
Research Paper
Signal Transduction
Cell Survival
Phosphatidate Phosphatase
Breast Neoplasms
Biology
Transfection
Cell Line
Tumor

medicine
Autophagy
Humans
Rapamycin
Protein kinase B
Diacylglycerol kinase
Cell Proliferation
Sirolimus
Dose-Response Relationship
Drug

Cell growth
rapamycin
Lipogenesis
Cancer
Prostatic Neoplasms
RhoA
medicine.disease
Metabolism
chemistry
Cancer cell
Cancer research
biology.protein
rhoA GTP-Binding Protein
metabolism
Proto-Oncogene Proteins c-akt
Zdroj: Oncotarget
Brohée, L, Demine, S, Willems, J, Arnould, T, Colige, A C & Deroanne, C F 2015, ' Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment ', Oncotarget, vol. 6, no. 13, pp. 11264-11280 .
ISSN: 1949-2553
Popis: Lipogenesis inhibition was reported to induce apoptosis and repress proliferation of cancer cells while barely affecting normal cells. Lipins exhibit dual function as enzymes catalyzing the dephosphorylation of phosphatidic acid to diacylglycerol and as co-transcriptional regulators. Thus, they are able to regulate lipid homeostasis at several nodal points. Here, we show that lipin-1 is up-regulated in several cancer cell lines and overexpressed in 50 % of high grade prostate cancers. The proliferation of prostate and breast cancer cells, but not of non-tumorigenic cells, was repressed upon lipin-1 knock-down. Lipin-1 depletion also decreased cancer cell migration through RhoA activation. Lipin-1 silencing did not significantly affect global lipid synthesis but enhanced the cellular concentration of phosphatidic acid. In parallel, autophagy was induced while AKT and ribosomal protein S6 phosphorylation were repressed. We also observed a compensatory regulation between lipin-1 and lipin-2 and demonstrated that their co-silencing aggravates the phenotype induced by lipin-1 silencing alone. Most interestingly, lipin-1 depletion or lipins inhibition with propranolol sensitized cancer cells to rapamycin. These data indicate that lipin-1 controls main cellular processes involved in cancer progression and that its targeting, alone or in combination with other treatments, could open new avenues in anticancer therapy.
Databáze: OpenAIRE